G1 Therapeutics, Inc. announced the appointment of Monica Thomas as its General Counsel and Chief Compliance Officer. Mrs. Thomas replaces Stillman Hanson who departed the Company in May 2023. Mrs. Thomas brings nearly two decades of leadership experience in securities filings and corporate governance, global regulatory engagement, and all aspects of legal support for commercialization of drug products/biologics.

Mrs. Thomas has joined G1 after serving as Head of Corporate Legal and Assistant Corporate Secretary at Radius Health where she advised senior executives and the Board of Directors, established a framework for successful commercialization in Japan, and oversaw the resolution of costly litigation. Previously, she was Associate General Counsel for UCB, Inc. where she supported the launch of a reimagined Rare Disease organization. Prior to that, she held numerous leadership roles over 12 years with GlaxoSmithKline, serving as legal lead on the launch of a first-in-industry TV advertisement for HIV medication, the commercialization of medications and biologics across multiple disease states, and the standardization of contracting policies and procedures for Global Manufacturing Supply.

Mrs. Thomas also served as a Corporate Securities Associate with Smith Anderson. She is admitted to the North Carolina state bar and earned a Juris Doctorate degree from North Carolina Central University School of Law and a Bachelor of Arts degree from Duke University.